CMV infection and CMV-specific immune reconstitution following haploidentical stem cell transplantation: an update
XH Luo, Y Zhu, YT Chen, LP Shui, L Liu - Frontiers in Immunology, 2021 - frontiersin.org
Haploidentical stem cell transplantation (haploSCT) has advanced to a common procedure
for treating patients with hematological malignancies and immunodeficiency diseases …
for treating patients with hematological malignancies and immunodeficiency diseases …
The evolution of T cell depleted haploidentical transplantation
F Aversa, A Pierini, L Ruggeri, MF Martelli… - Frontiers in …, 2019 - frontiersin.org
Work on bone marrow transplantation from haploidentical donor has been proceeding for
over 20 years all over the world and new transplant procedures have been developed. To …
over 20 years all over the world and new transplant procedures have been developed. To …
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients
WA Bethge, M Eyrich, S Mielke, R Meisel… - Bone Marrow …, 2022 - nature.com
Hematopoietic stem cell transplantation (HSCT) from haploidentical donors is a viable
option for patients lacking HLA-matched donors. Here we report the results of a prospective …
option for patients lacking HLA-matched donors. Here we report the results of a prospective …
Role of αβ T cell depletion in prevention of graft versus host disease
H Abdelhakim, H Abdel-Azim, A Saad - Biomedicines, 2017 - mdpi.com
Graft versus host disease (GVHD) represents a major complication of allogeneic
hematopoietic stem cell transplantation (allo HCT). Graft cellular manipulation has been …
hematopoietic stem cell transplantation (allo HCT). Graft cellular manipulation has been …
Peripheral blood stem cell mobilization in healthy donors by granulocyte colony-stimulating factor causes preferential mobilization of lymphocyte subsets
GK Melve, E Ersvaer, GE Eide… - Frontiers in …, 2018 - frontiersin.org
Background Allogeneic hematopoietic stem cell transplantation is associated with a high risk
of immune-mediated post-transplant complications. Graft depletion of immunocompetent cell …
of immune-mediated post-transplant complications. Graft depletion of immunocompetent cell …
T-cell manipulation strategies to prevent graft-versus-host disease in haploidentical stem cell transplantation
J Vadakekolathu, S Rutella - Biomedicines, 2017 - mdpi.com
Allogeneic haematopoietic stem cell transplantation (HSCT) from an human leukocyte
antigen (HLA)-identical donor can be curative for eligible patients with non-malignant and …
antigen (HLA)-identical donor can be curative for eligible patients with non-malignant and …
T-Cell-Replete Versus ex vivo T-Cell-Depleted Haploidentical Haematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukaemia and Other …
K Kleinschmidt, M Lv, A Yanir, J Palma, P Lang… - Frontiers in …, 2021 - frontiersin.org
Allogeneic haematopoietic stem cell transplantation (HSCT) represents a potentially curative
option for children with high-risk or refractory/relapsed leukaemias. Traditional donor …
option for children with high-risk or refractory/relapsed leukaemias. Traditional donor …
The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia
One of the consistent features in development of hematopoietic stem cell transplant (HCT)
for Acute Lymphoblastic Leukemia (ALL) is the rapidity with which discoveries in the …
for Acute Lymphoblastic Leukemia (ALL) is the rapidity with which discoveries in the …
Hematopoietic stem cell transplant with HLA-mismatched grafts: impact of donor, source, conditioning, and graft versus host disease prophylaxis
L Metheny, M de Lima - Expert Review of Hematology, 2019 - Taylor & Francis
Introduction: Allogeneic hematopoietic cell transplantation is frequently used to treat
malignant and non-malignant conditions, and many patients lack a human leukocyte antigen …
malignant and non-malignant conditions, and many patients lack a human leukocyte antigen …
Effective T‐cell replete haploidentical stem cell transplantation for pediatric patients with high‐risk hematologic disorders
S Tannumsaeung, U Anurathapan… - European Journal of …, 2023 - Wiley Online Library
Objectives Patients with high‐risk hematologic diseases require intensive modalities,
including high‐dose chemotherapy and allogeneic hematopoietic stem cell transplantation …
including high‐dose chemotherapy and allogeneic hematopoietic stem cell transplantation …